{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Papier : Questions médicales les plus fréquentes",
"headline": "Papier : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Papier : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-02",
"dateModified": "2025-03-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Papier"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Produits manufacturés",
"url": "https://questionsmedicales.fr/mesh/D008420",
"about": {
"@type": "MedicalCondition",
"name": "Produits manufacturés",
"code": {
"@type": "MedicalCode",
"code": "D008420",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Papier",
"alternateName": "Paper",
"code": {
"@type": "MedicalCode",
"code": "D010209",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mario Manto",
"url": "https://questionsmedicales.fr/author/Mario%20Manto",
"affiliation": {
"@type": "Organization",
"name": "Service de Neurologie, Médiathèque Jean Jacquy, CHU-Charleroi, 6000, Charleroi, Belgium. mario.manto@ulb.be."
}
},
{
"@type": "Person",
"name": "Hiroshi Mitoma",
"url": "https://questionsmedicales.fr/author/Hiroshi%20Mitoma",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Education, Tokyo Medical University, Tokyo, 160-8402, Japan."
}
},
{
"@type": "Person",
"name": "Cristina Candal-Pedreira",
"url": "https://questionsmedicales.fr/author/Cristina%20Candal-Pedreira",
"affiliation": {
"@type": "Organization",
"name": "Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain."
}
},
{
"@type": "Person",
"name": "Joseph S Ross",
"url": "https://questionsmedicales.fr/author/Joseph%20S%20Ross",
"affiliation": {
"@type": "Organization",
"name": "Section of General Internal Medicine and National Clinician Scholars Program, Yale School of Medicine, New Haven, CT, USA."
}
},
{
"@type": "Person",
"name": "Alberto Ruano-Ravina",
"url": "https://questionsmedicales.fr/author/Alberto%20Ruano-Ravina",
"affiliation": {
"@type": "Organization",
"name": "Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Programmed cell death-1 blockade therapy in melanoma: Resistance mechanisms and combination strategies.",
"datePublished": "2023-01-24",
"url": "https://questionsmedicales.fr/article/36645031",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/exd.14750"
}
},
{
"@type": "ScholarlyArticle",
"name": "MicroRNAs Targeting Programmed Cell Death Protein 1 (PD-1) Promote Natural Killer Cell Exhaustion in Rheumatoid Arthritis.",
"datePublished": "2022-12-24",
"url": "https://questionsmedicales.fr/article/36640056",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18502/ijaai.v21i6.11524"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy.",
"datePublished": "2023-04-21",
"url": "https://questionsmedicales.fr/article/37153623",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1138145"
}
},
{
"@type": "ScholarlyArticle",
"name": "A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/35758515",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2340/actadv.v102.1062"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36442821",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.actbio.2022.11.043"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits manufacturés",
"item": "https://questionsmedicales.fr/mesh/D008420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Papier",
"item": "https://questionsmedicales.fr/mesh/D010209"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Papier - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Papier",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Papier",
"description": "Comment évaluer la qualité du papier médical ?\nQuels tests pour détecter les contaminants sur le papier ?\nComment identifier le type de papier utilisé ?\nQuels critères pour le papier d'impression médicale ?\nComment vérifier la durabilité du papier ?",
"url": "https://questionsmedicales.fr/mesh/D010209?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Papier",
"description": "Quels problèmes causent des papiers de mauvaise qualité ?\nComment le papier affecte-t-il la lisibilité ?\nQuels effets d'un papier non adapté sur la santé ?\nLe papier recyclé peut-il causer des problèmes ?\nQuels symptômes d'une exposition prolongée au papier ?",
"url": "https://questionsmedicales.fr/mesh/D010209?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Papier",
"description": "Comment choisir un papier de qualité ?\nQuelles pratiques pour réduire les allergies au papier ?\nComment stocker le papier pour éviter la dégradation ?\nQuelles mesures pour éviter la contamination du papier ?\nComment sensibiliser sur l'utilisation du papier ?",
"url": "https://questionsmedicales.fr/mesh/D010209?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Papier",
"description": "Comment traiter les allergies au papier ?\nQuelles alternatives au papier pour les documents ?\nComment nettoyer le papier contaminé ?\nQuels traitements pour les irritations cutanées ?\nComment gérer les problèmes respiratoires liés au papier ?",
"url": "https://questionsmedicales.fr/mesh/D010209?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Papier",
"description": "Quelles complications liées à l'utilisation de papier recyclé ?\nComment le papier peut-il causer des infections ?\nQuels risques d'irritations cutanées avec certains papiers ?\nComment le papier peut-il affecter la santé respiratoire ?\nQuelles complications liées à l'impression sur papier ?",
"url": "https://questionsmedicales.fr/mesh/D010209?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Papier",
"description": "Quels facteurs augmentent les allergies au papier ?\nComment l'environnement de travail influence-t-il la santé liée au papier ?\nQuels types de papier sont plus risqués pour la santé ?\nComment l'âge influence-t-il les réactions au papier ?\nQuels comportements augmentent les risques liés au papier ?",
"url": "https://questionsmedicales.fr/mesh/D010209?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la qualité du papier médical ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La qualité du papier médical se mesure par sa résistance, sa texture et sa compatibilité avec l'encre."
}
},
{
"@type": "Question",
"name": "Quels tests pour détecter les contaminants sur le papier ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests chimiques et microbiologiques peuvent être effectués pour détecter les contaminants."
}
},
{
"@type": "Question",
"name": "Comment identifier le type de papier utilisé ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par l'analyse de la composition, de l'épaisseur et de la texture."
}
},
{
"@type": "Question",
"name": "Quels critères pour le papier d'impression médicale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le papier doit être sans acide, résistant à l'humidité et compatible avec les imprimantes."
}
},
{
"@type": "Question",
"name": "Comment vérifier la durabilité du papier ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durabilité peut être testée par des essais de vieillissement et d'exposition à l'humidité."
}
},
{
"@type": "Question",
"name": "Quels problèmes causent des papiers de mauvaise qualité ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des papiers de mauvaise qualité peuvent causer des impressions floues ou des déchirures."
}
},
{
"@type": "Question",
"name": "Comment le papier affecte-t-il la lisibilité ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un papier trop brillant ou rugueux peut nuire à la lisibilité des documents imprimés."
}
},
{
"@type": "Question",
"name": "Quels effets d'un papier non adapté sur la santé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un papier non adapté peut libérer des particules nocives, provoquant des allergies ou irritations."
}
},
{
"@type": "Question",
"name": "Le papier recyclé peut-il causer des problèmes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le papier recyclé peut contenir des résidus chimiques pouvant affecter la santé."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une exposition prolongée au papier ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des irritations cutanées ou respiratoires."
}
},
{
"@type": "Question",
"name": "Comment choisir un papier de qualité ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Optez pour des papiers certifiés sans acide et testés pour la sécurité."
}
},
{
"@type": "Question",
"name": "Quelles pratiques pour réduire les allergies au papier ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des papiers hypoallergéniques et maintenez un environnement propre."
}
},
{
"@type": "Question",
"name": "Comment stocker le papier pour éviter la dégradation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conservez le papier dans un endroit frais et sec, à l'abri de la lumière directe."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter la contamination du papier ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des gants lors de la manipulation et stockez dans des conditions contrôlées."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser sur l'utilisation du papier ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organisez des formations sur les impacts environnementaux et la sécurité du papier."
}
},
{
"@type": "Question",
"name": "Comment traiter les allergies au papier ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec le papier allergène et utiliser des antihistaminiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles alternatives au papier pour les documents ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les alternatives incluent les formats numériques, les tablettes et les écrans interactifs."
}
},
{
"@type": "Question",
"name": "Comment nettoyer le papier contaminé ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le papier contaminé doit être éliminé selon les protocoles de déchets dangereux."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les irritations cutanées ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les irritations peuvent être traitées avec des crèmes apaisantes et des antihistaminiques."
}
},
{
"@type": "Question",
"name": "Comment gérer les problèmes respiratoires liés au papier ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition et consulter un médecin pour des traitements appropriés."
}
},
{
"@type": "Question",
"name": "Quelles complications liées à l'utilisation de papier recyclé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le papier recyclé peut contenir des contaminants chimiques, entraînant des risques pour la santé."
}
},
{
"@type": "Question",
"name": "Comment le papier peut-il causer des infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le papier contaminé peut être un vecteur de bactéries, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Quels risques d'irritations cutanées avec certains papiers ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des papiers traités chimiquement peuvent provoquer des irritations cutanées chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Comment le papier peut-il affecter la santé respiratoire ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La poussière de papier peut aggraver les problèmes respiratoires, surtout chez les allergiques."
}
},
{
"@type": "Question",
"name": "Quelles complications liées à l'impression sur papier ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des encres toxiques peuvent causer des problèmes de santé si le papier est mal utilisé."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent les allergies au papier ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies et l'exposition fréquente au papier augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'environnement de travail influence-t-il la santé liée au papier ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement poussiéreux ou humide peut exacerber les problèmes de santé liés au papier."
}
},
{
"@type": "Question",
"name": "Quels types de papier sont plus risqués pour la santé ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les papiers traités chimiquement ou recyclés peuvent présenter des risques pour la santé."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les réactions au papier ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées peuvent être plus sensibles aux irritations et allergies liées au papier."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent les risques liés au papier ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Manipuler le papier sans protection ou dans des environnements non contrôlés augmente les risques."
}
}
]
}
]
}
Melanoma is a highly aggressive tumor derived from melanocytes. In recent years, the incidence and mortality of melanoma have gradually increased, seriously threatening human health. Classic treatment...
Natural killer (NK) cells play a role in the pathogenesis of rheumatoid arthritis (RA). Upregulated levels of programmed cell death protein 1 (PD-1) is a sign of exhausted NK cells that could be regul...
Erythroderma is challenging to diagnose. The aim of this single-centre retrospective study was to identify factors that can be used to improve the diagnosis of erythroderma. Among 91 patients with ery...
Immune checkpoint blockade therapy targeting programmed death-1 (PD-1) or its major ligand programmed death-ligand 1 (PD-L1) has achieved remarkable success in the treatment of several tumors, includi...
The immune system uses various immune checkpoint axes to adjust responses, support homeostasis, and deter self-reactivity and autoimmunity. Nevertheless, non-small-cell lung carcinoma (NSCLC) can use ...
Pembrolizumab or nivolumab plus chemotherapy was approved as a first-line treatment for high programmed cell death ligand 1 (PD-L1)-expressing esophageal squamous cell carcinoma (ESCC) by the European...
Post hoc analysis of the Chinese JUPITER-06 study focusing on efficacy stratified by PD-L1 tumor proportion score (TPS; using JS311 antibody) was conducted. Electronic databases were searched to ident...
The post hoc analysis of JUPITER-06 showed more prominent clinical benefit with PD-1 antibody plus chemotherapy than with chemotherapy alone in both the high and low PD-L1-expressing subgroups. Five r...
This study provided novel evidence supporting the superiority of PD-1 antibody plus chemotherapy to chemotherapy alone in patients with advanced ESCC with low PD-L1 expression. Further studies of pred...
Major depression (MD) may be associated with inflammation and immunity. PD-1 (programmed death-1), PD-L1 (programmed death-ligand 1) and PD-L2 (programmed death-ligand 2) are among the inhibitory immu...
During a period of 2 years, patients with MD and healthy controls were recruited from a medical centre in this study. The diagnosis of MD was established according to the DSM-5 criteria. The severity ...
A total of 54 patients with MD and 38 healthy controls were recruited. According to the analyses, there is a significantly higher PD-L2 level in MD than in healthy controls and lower PD-1 level after ...
It was found that PD-1 pathway might play an important role in MD. We need a large sample to prove these results in the future....
Tumor-infiltrating lymphocytes are detectable in up to 75% of triple-negative breast cancer. The composition of these infiltrates may influence prognosis and is not known regarding regulatory or effec...
This was a retrospective observational study. Clinical and pathological data from 38 triple-negative breast cancer patients treated with neoadjuvant chemotherapy at the University Hospital (HUCFF/UFRJ...
Statistically significant changes in stromal tumor-infiltrating lymphocyte categories were observed before and post-neoadjuvant chemotherapy, with 32% of intermediate cases becoming high. The correlat...
In this study, we observed that chemotherapy significantly increases stromal tumor-infiltrating lymphocytes, CD8 T cells, as well as CD8/FoxP3 ratio. Most importantly, programmed cell death protein 1 ...
Melanoma is widely treated with programmed cell death-1 (PD-1) inhibitors. As part of their anti-tumor immunity effect, they increase the susceptibility to cutaneous immune-related adverse events (cIR...